DIAMAP

Road Map for Diabetes Research in Europe

 Coordinatore EURADIA EV 

 Organization address address: RHEINDORFER WEG 3
city: DUESSELDORF
postcode: 40591

contact info
Titolo: Prof.
Nome: Philippe
Cognome: Halban
Email: send email
Telefono: + 41 22 379 5536
Fax: + 41 22 379 5528

 Nazionalità Coordinatore Germany [DE]
 Sito del progetto http://www.diamap.eu/
 Totale costo 610˙524 €
 EC contributo 530˙970 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-A
 Funding Scheme CSA-SA
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-04-01   -   2010-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    EURADIA EV

 Organization address address: RHEINDORFER WEG 3
city: DUESSELDORF
postcode: 40591

contact info
Titolo: Prof.
Nome: Philippe
Cognome: Halban
Email: send email
Telefono: + 41 22 379 5536
Fax: + 41 22 379 5528

DE (DUESSELDORF) coordinator 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

credibility    contact    report    survey    expert    diamap    profile    fora    landscape    input    euradia    maps    strengths    patient    diabetes    road    scientific    strategy   

 Obiettivo del progetto (Objective)

'EURADIA, the Alliance for European Diabetes Research, encompasses in one entity the major European diabetes stakeholder organisations, ensuring contact and credibility with scientists in all fields of diabetes research. EURADIA has a unique and high profile at European level and is the primary contact for the European Commission in diabetes research issues. EURADIA has been instrumental in highlighting the need for increased and better coordinated funding for diabetes research. A Project Steering Committee of high-profile EURADIA members (from patient organisations, academic science and industry) will provide scientific guidance for the DIAMAP project. The solid scientific backing for DIAMAP, patient input, and established tools such as a website and database, and links with the Innovative Medicines Initiative, provide credibility for DIAMAP to survey the European diabetes research landscape and to invite input from experts (through expert scientific fora in different diabetes research areas) to produce ‘Road Maps’ for diabetes research. Road Maps will be compiled into a single report to provide the European Commission, funding agencies and researchers with a strategy to maximize the strengths and opportunities for future diabetes research in Europe. Stakeholders will participate through fora for horizontal issues: legal, ethical, health professional. The final diabetes Road Maps will be disseminated widely in the form of an expert report. The mission of DIAMAP is to undertake a wide survey of the current European diabetes research landscape, from which expert opinion can identify gaps and highlight strengths, to guide a Road Map strategy for diabetes research in Europe.'

Altri progetti dello stesso programma (FP7-HEALTH)

AMBULUNG (2012)

Ambulatory Bio-Artificial Lung

Read More  

IMPACTT (2011)

Immunoglobulin IgY pseudomonas A clinical trial for cystic fibrosis treatment

Read More  

PRATH (2010)

Preclinical study of Recombinant human Anti-C5 for the Treatment of atypical HUS

Read More